Vetoquinol, a French animal health company, reported sales of €259 million for the first half of 2026, up 3.4% at constant exchange rates and 0.7% on a reported basis. Essential Products sales reached €169 million, growing 3.7% at constant exchange rates. The company posted earnings before interest and tax of €45 million, representing 17.3% of sales. Net income totalled €30 million, or 11.8% of sales. Cash flow generation was €59 million. Growth was driven by strong performance in the US market, where sales rose 13.1% in the first half. Essential Products now account for two-thirds of total sales. The company said it is preparing several new product launches.

Vetoquinol, a French animal health company, reported first-quarter 2026 sales of €125 million, down 4.3% on a reported basis but flat at constant exchange rates. Excluding currency effects and a product line simplification programme, sales increased 1.2% year-on-year. Exchange rate headwinds reached €5.2 million, primarily affecting the United States and India. The product line simplification programme impacted sales by €1.7 million. Essential products sales totalled €83 million, stable at constant exchange rates, whilst complementary products grew, driven by strong US performance. US sales rose 15.6% at constant exchange rates to €28 million. Companion animal products represented 71% of sales at €93 million, whilst farm animal products totalled €38 million. The company described 2026 as a transition year ahead of new product launches in 2027.

Vetoquinol launches Command Centre ACT. The platform creates 'clear accountability' and eases the administrative burden of tracking vaccinations and farm visits. A veterinary pharmaceutical company has launched a dashboard to help ease administrative burdens on farm and mixed practices and drive revenue growth and clinical compliance. Vetoquinol has launched Command Centre ACT, a dashboard extension for its VetImpress data management platform designed for clinical directors and business development staff. The extension is said to draw on practices' data stored within VetImpress or their practice management system to identify revenue opportunities and compliance gaps. Based on analysis using leptospirosis, bovine viral diarrhoea and infectious bovine rhinotracheitis, Vetoquinol estimates that in dairy herds alone, missed vaccination doses, lapsed vaccinations and unvaccinated herds demonstrate an opportunity of around £2,877 annually per farm vet. 'Strategic approach' As well as optimising vaccine scheduling and compliance, Command Centre ACT is said to address regulatory requirements such as Veterinary Medicines Requirements "animals under care" guidelines, automatically flagging farms that are due visits to visually inspect livestock. Vetoquinol product manager Andy Paine said: "The dashboard's name reflects its strategic approach to practice management. "Command Centre ACT enables the user to identify farms requiring attention and assign specific follow-up actions to individual vets through the VetImpress diary and tasks system, creating clear accountability whilst maintaining clinical focus. "We're ultimately selling accountability, but we're striking the right balance between management oversight and clinical autonomy." Work and well being 20 Apr 2026 Small animal 3 Mar 2026